NG
Nalin Gupta
About Nalin Gupta
Data last updated:
Nalin Gupta is a Director at Jaipur Hospital Multispeciality Private Limited (since 2025), Director at Maxlink Stonex Private Limited (since 2024) and Director at Healthvista Pharma Private Limited (since 2024). The companies operate in Healthcare, Manufacturing and Paper.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jaipur Hospital Multispeciality Private Limited U86100RJ2025PTC101964 | Director | 18 Apr 2025 | 2025 | Active | |
| Maxlink Stonex Private Limited U46900RJ2024PTC094835 | Director | 29 May 2024 | 2024 | Active | |
| Healthvista Pharma Private Limited U21003RJ2024PTC092766 | Director | 18 Feb 2024 | 2024 | Active |
Board colleagues of Nalin Gupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vijay Gupta | 11063457 | Jaipur Hospital Multispeciality Private Limited | Director |
| Sudha Mittal | 10512880 | Maxlink Stonex Private Limited , Healthvista Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nalin Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nalin Gupta
Nalin Gupta currently holds 3 directorships: Jaipur Hospital Multispeciality Private Limited (Director, since 18 Apr 2025); Maxlink Stonex Private Limited (Director, since 29 May 2024); Healthvista Pharma Private Limited (Director, since 18 Feb 2024).
Nalin Gupta was first appointed on 18 Feb 2024 as Director at Healthvista Pharma Private Limited. The most recent appointment on record is 18 Apr 2025 at Jaipur Hospital Multispeciality Private Limited.
The current boards of Nalin Gupta's companies include Vijay Gupta (Jaipur Hospital Multispeciality Private Limited), Sudha Mittal (Maxlink Stonex Private Limited).